title: Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study.
abstract: A minimally invasive test for early detection and monitoring of Alzheimer's and other neurodegenerative diseases is a highly unmet need for drug development and planning of patient care. Mild Cognitive Impairment (MCI) is a syndrome characteristic of early stages of many neurodegenerative diseases. Recently, we have identified two sets of circulating brain-enriched miRNAs, the miR-132 family (miR-128, miR-132, miR-874) normalized per miR-491-5p and the miR-134 family (miR-134, miR-323-3p, miR-382) normalized per miR-370, capable of differentiating MCI from age-matched control (AMC) with high accuracy. Here we report a biomarker validation study of the identified miRNA pairs using larger independent sets of age- and gender- matched plasma samples. The biomarker pairs detected MCI with sensitivity, specificity and overall accuracy similar to those obtained in the first study. The miR-132 family biomarkers differentiated MCI from AMC with 84%-94% sensitivity and 96%-98% specificity, and the miR-134 family biomarkers demonstrated 74%-88% sensitivity and 80-92% specificity. When miRNAs of the same family were combined, miR-132 and miR-134 family biomarkers demonstrated 96% and 87% overall accuracy, respectively. No statistically significant differences in the biomarker concentrations in samples obtained from male and female subjects were observed for either MCI or AMC. The present study also demonstrated that the highest sensitivity and specificity are achieved with pairs of miRNAs whose concentrations in plasma are highly correlated.
authors.affiliation: DiamiR, LLC, Princeton, NJ 08852, USA;
authors.forename: Kira S
authors.initials: KS
authors.lastname: Sheinerman
authors.forename: Vladimir G
authors.initials: VG
authors.lastname: Tsivinsky
authors.forename: Laila
authors.initials: L
authors.lastname: Abdullah
authors.forename: Fiona
authors.initials: F
authors.lastname: Crawford
authors.forename: Samuil R
authors.initials: SR
authors.lastname: Umansky
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood* / Q000378:metabolism; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D016022:Case-Control Studies; D060825:Cognitive Dysfunction / Q000097:blood* / Q000175:diagnosis / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000097:blood* / Q000378:metabolism*; D008875:Middle Aged; D015203:Reproducibility of Results
chemical_list: D015415:Biomarkers; D035683:MicroRNAs